Laxmi Berwa
Internal Medicine · Clinton, MDNPI 1215937776
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,205 and has fallen 71.4% since, to $345 in 2025.
Across 178 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$467
- Pfizer$335
- AstraZeneca$244
- Merck$239
- Sanofi-aventis U.S. LLC$195
- Lilly USA, LLC$178
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,117100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $467 |
| Pfizer | 17 | $335 |
| AstraZeneca | 13 | $244 |
| Merck | 15 | $239 |
| Sanofi-aventis U.S. LLC | 10 | $195 |
| Lilly USA, LLC | 10 | $178 |
| Novartis | 14 | $176 |
| Bayer | 7 | $145 |
| Exact Sciences | 5 | $118 |
| AbbVie(2 entities) | 4 | $100 |
| E.r. Squibb & Sons, L.L.C. | 5 | $98 |
| Boehringer Ingelheim | 5 | $93 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $78 |
| GSK | 4 | $74 |
| Amarin Pharma, Inc. | 4 | $68 |
| Amgen(2 entities) | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $45 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $43 |
| Johnson & Johnson | 2 | $40 |
| Seqirus USA Inc | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Abbott | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 2 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic | 1 | $20 |
| Phadia US Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $11 |
How this compares
$3,117 in reported general payments places this provider in the 85th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Clinton
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Brian HarveyAnnapolis$220K
- Jeremy SugarmanBaltimore$210K
- Florence HounPotomac$161K
- Matthew MintzBethesda$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.